Determinants of orphan drugs prices in France: a regression analysis

Determinants of orphan drugs prices in France: a regression analysis

Abstract Background The introduction of the orphan drug legislation led to the increase in the number of available orphan drugs, but the access to them is often limited due to the high price. Social preferences regarding funding orphan drugs as well as the criteria taken into consideration while set...

Full description

Bibliographic Details
Main Authors: Daria Korchagina, Aurelie Millier, Anne-Lise Vataire, Samuel Aballea, Bruno Falissard, Mondher Toumi
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Orphan drugs
Rare disease
Technology assessment
Pricing
Drug costs
Online Access:http://link.springer.com/article/10.1186/s13023-016-0561-5

Internet

http://link.springer.com/article/10.1186/s13023-016-0561-5

Similar Items